These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 15708912)
1. Muscarinic acetylcholine receptor autoantibodies in patients with Sjögren's syndrome. Naito Y; Matsumoto I; Wakamatsu E; Goto D; Sugiyama T; Matsumura R; Ito S; Tsutsumi A; Sumida T Ann Rheum Dis; 2005 Mar; 64(3):510-1. PubMed ID: 15708912 [No Abstract] [Full Text] [Related]
2. High prevalence of autoantibodies to muscarinic-3 acetylcholine receptor in patients with juvenile-onset Sjögren syndrome. Nakamura Y; Wakamatsu E; Matsumoto I; Tomiita M; Kohno Y; Mori M; Yokota S; Goto D; Ito S; Tsutsumi A; Sumida T Ann Rheum Dis; 2008 Jan; 67(1):136-7. PubMed ID: 18077545 [No Abstract] [Full Text] [Related]
3. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome. Waterman SA; Gordon TP; Rischmueller M Arthritis Rheum; 2000 Jul; 43(7):1647-54. PubMed ID: 10902771 [TBL] [Abstract][Full Text] [Related]
4. Antimuscarinic antibodies in Sjögren's syndrome: where are we, and where are we going? Dawson L; Tobin A; Smith P; Gordon T Arthritis Rheum; 2005 Oct; 52(10):2984-95. PubMed ID: 16200578 [No Abstract] [Full Text] [Related]
5. Failure to detect antibodies to extracellular loop peptides of the muscarinic M3 receptor in primary Sjögren's syndrome. Cavill D; Waterman SA; Gordon TP J Rheumatol; 2002 Jun; 29(6):1342-4. PubMed ID: 12064859 [No Abstract] [Full Text] [Related]
6. Muscarinic acetylcholine type-3 receptor desensitization due to chronic exposure to Sjögren's syndrome-associated autoantibodies. Cha S; Singson E; Cornelius J; Yagna JP; Knot HJ; Peck AB J Rheumatol; 2006 Feb; 33(2):296-306. PubMed ID: 16465661 [TBL] [Abstract][Full Text] [Related]
7. Demonstration of autoantibody binding to muscarinic acetylcholine receptors in the salivary gland in primary Sjögren's syndrome. Kovács L; Fehér E; Bodnár I; Marczinovits I; Nagy GM; Somos J; Boda V Clin Immunol; 2008 Aug; 128(2):269-76. PubMed ID: 18508410 [TBL] [Abstract][Full Text] [Related]
8. Anti-M(3) muscarinic cholinergic autoantibodies from patients with primary Sjögren's syndrome trigger production of matrix metalloproteinase-3 (MMP-3) and prostaglandin E(2) (PGE(2)) from the submandibular glands. Reina S; Sterin-Borda L; Passafaro D; Borda E Arch Oral Biol; 2011 May; 56(5):413-20. PubMed ID: 21371688 [TBL] [Abstract][Full Text] [Related]
9. Autoantibodies against lacrimal gland M3 muscarinic acetylcholine receptors in patients with primary Sjögren's syndrome. Bacman S; Perez Leiros C; Sterin-Borda L; Hubscher O; Arana R; Borda E Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):151-6. PubMed ID: 9430556 [TBL] [Abstract][Full Text] [Related]
10. Activation of nitric oxide signaling through muscarinic receptors in submandibular glands by primary Sjögren syndrome antibodies. Pérez Leirós C; Sterin-Borda L; Hubscher O; Arana R; Borda ES Clin Immunol; 1999 Feb; 90(2):190-5. PubMed ID: 10080830 [TBL] [Abstract][Full Text] [Related]
11. Does autonomic nervous impairment have a role in pathophysiology of Sjögren's syndrome. Hakala M; Niemelä RK Lancet; 2000 Mar; 355(9209):1032-3. PubMed ID: 10744085 [No Abstract] [Full Text] [Related]
12. Clinical associations of autoantibodies to human muscarinic acetylcholine receptor 3(213-228) in primary Sjogren's syndrome. Kovács L; Marczinovits I; György A; Tóth GK; Dorgai L; Pál J; Molnár J; Pokorny G Rheumatology (Oxford); 2005 Aug; 44(8):1021-5. PubMed ID: 15888503 [TBL] [Abstract][Full Text] [Related]
13. Detection of anti-type 3 muscarinic acetylcholine receptor autoantibodies in the sera of Sjögren's syndrome patients by use of a transfected cell line assay. Gao J; Cha S; Jonsson R; Opalko J; Peck AB Arthritis Rheum; 2004 Aug; 50(8):2615-21. PubMed ID: 15334476 [TBL] [Abstract][Full Text] [Related]
14. Do male patients with primary Sjögren's syndrome have a higher frequency of autoantibodies? Ramos-Casals M; Cervera R; Font J J Rheumatol; 2005 Aug; 32(8):1634-5; author reply 1635-6. PubMed ID: 16078351 [No Abstract] [Full Text] [Related]
15. Current issues in Sjögren's syndrome. Jonsson R; Moen K; Vestrheim D; Szodoray P Oral Dis; 2002 May; 8(3):130-40. PubMed ID: 12108757 [TBL] [Abstract][Full Text] [Related]
16. Are autoantibodies against a 25-mer synthetic peptide of M3 muscarinic acetylcholine receptor a new diagnostic marker for Sjögren's syndrome? Zigon P; Bozic B; Cucnik S; Rozman B; Tomsic M; Kveder T Ann Rheum Dis; 2005 Aug; 64(8):1247; author reply 1247. PubMed ID: 16014696 [No Abstract] [Full Text] [Related]
17. Absence of anticardiolipin antibodies in patients with primary Sjögren's syndrome. Müller K; Oxholm P; Madsen MH; Wiik A Autoimmunity; 1988; 2(1):92-3. PubMed ID: 3155155 [No Abstract] [Full Text] [Related]
18. A peptide of human muscarinic acetylcholine receptor 3 is antigenic in primary Sjogren's syndrome. Marczinovits I; Kovács L; György A; Tóth GK; Dorgai L; Molnár J; Pokorny G J Autoimmun; 2005 Feb; 24(1):47-54. PubMed ID: 15725576 [TBL] [Abstract][Full Text] [Related]
19. Human primary Sjögren's syndrome autoantibodies as mediators of nitric oxide release coupled to lacrimal gland muscarinic acetylcholine receptors. Bacman SR; Berra A; Sterin-Borda L; Borda ES Curr Eye Res; 1998 Dec; 17(12):1135-42. PubMed ID: 9872535 [TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid anti-SSA autoantibodies in primary Sjogren's syndrome with central nervous system involvement. Mégevand P; Chizzolini C; Chofflon M; Roux-Lombard P; Lalive PH; Picard F Eur Neurol; 2007; 57(3):166-71. PubMed ID: 17213724 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]